Alnylam Pharmaceuticals
Neelroop P. is an experienced leader in neuroscience and genomics, currently serving as Director of Next Wave Research at Alnylam Pharmaceuticals since January 2025, focusing on siRNA therapeutics. Previously, Neelroop held the position of Director of Neuroscience and Ophthalmology Translational Genetics at Regeneron and served as Associate Director at the University of California, San Francisco, where involvement included outpatient neurology and research in single-cell genomics. Neelroop's consulting experience encompasses bioinformatics and genetics across various biotechnology and healthcare companies. An academic background includes a Doctor of Medicine and a Doctor of Philosophy in Neuroscience from UCLA, along with a BA in Biochemistry and Cell Biology and a BA in Mathematics from Rice University.
This person is not in any teams
Alnylam Pharmaceuticals
29 followers
Alnylam is the world's leading RNAi therapeutics company and the first and only company to bring an RNAi medicine to market.